The effect of childhood cancer therapy on ovarian reserve and pubertal development


Creative Commons License

Akar B., DOĞER E., Cakiroglu Y., Corapcioglu F., SARPER N., Caliskan E.

REPRODUCTIVE BIOMEDICINE ONLINE, cilt.30, sa.2, ss.175-180, 2015 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 30 Sayı: 2
  • Basım Tarihi: 2015
  • Doi Numarası: 10.1016/j.rbmo.2014.10.010
  • Dergi Adı: REPRODUCTIVE BIOMEDICINE ONLINE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.175-180
  • Kocaeli Üniversitesi Adresli: Evet

Özet

The effects of childhood cancer therapy on ovarian reserve tests and on pubertal development within 5 years were compared with a control group. The study group was composed of 41 patients who underwent chemotherapy during pre-menarche (subgroup A; n = 15) and after menarche (subgroup B; n = 26); the control group was composed of 44 patients admitted with non-cancer related diseases (in total n = 85). Mean total ovarian volume and total antral follicle counts on ultrasound examination were significantly lower in the study group compared with the control group (3.5 +/- 2.3 versus 5.2 +/- 2.4 ml; P = 0.001; and 3.4 +/- 3.3 versus 8.6 +/- 3.5; P < 0.001, respectively). Mean FSH level was significantly higher in the study group (13.5 +/- 16.2 versus 7.3 +/- 2.7 mIU/ml; P = 0.017). Anti-Mullerian hormone levels in subgroup A A were significantly higher than in subgroup B (1.8 +/- 0.1 versus 1.5 +/- 0.08 pg/dl; P = 0.034). In conclusion ovarian volume, antral follicle count and FSH can be used for evaluating the harmful effect of cancer chemotherapy on ovarian follicles. Post-menarche, Anti-Mullerian values reveal that ovarian follicles are more sensitive to the devastating effects of cytotoxic treatment. (C) 2014 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.